Delivering the Added Dimension in Drug Discovery Services
A showcase of drug discovery capabilities in NASH, with special focus on animal models; current challenges and way forward. Current challenges in testing drugs in NASH animal models will be discussed with suggestions to consider new ways of testing to get better outcomes
Dr. Sanjay V Kadnur
Principal Scientist, Computational Chemistry
Dr. Kadnur is a Drug Hunter has more than 16 years’ experience in Metabolic and Inflammatory Diseases Biology and In-vivo Pharmacology and has been associated with Jubilant Biosys for the past 12 years. Prior to joining Jubilant, Dr. Kadnur has worked with multiple emerging indian Biotechs pursing research.
Dr. Kadnur holds M.Pharm, Pharmacology from Rajiv Gandhi University of Health Sciences and received his PhD from LM College of Pharmacy.
At Jubilant Biosys, Dr. Kadnur leads some of the key Integrated Drug Discovery programs spanning inflammatory diseases, diabetes and obesity to aid in-vivo pharmacology efforts that lead to several molecules in Phase 2 studies. Has immensely contributed in the publication of several scientific papers and patents.
Senior Vice President – Global Business Development
Saurabh has over 19 years of experience in corporate and international business development in pharmaceutical and drug discovery contract research organizations, marketing (product/brand management), strategic planning, alliance and process management.
He has worked across various geographies like Europe, North America and Asia wherein he created and built businesses from scratch. His experience is spread across multiple Indian pharma cos including Torrent Pharma, Piramal Enterprises and Dr. Reddy’s Laboratories where he worked in various businesses around branded generics and Drug Discovery service providers including Aurigene Discovery, AMRI Global and Panacea Biotech both in managerial and leadership roles.